Saudi Aid Center KSrelief Distributes Over $8.5 Billion to 114 Countries
Translated from English, summarized and contextualized by DistantNews.
At a glance
- The King Salman Humanitarian Aid and Relief Center (KSrelief) has provided $8.54 billion in aid through 4,404 projects in 114 countries as of June 2026.
- Yemen received the largest share of aid ($4.79 billion), followed by Syria, Palestine, Somalia, Pakistan, and Sudan.
- Food security and health projects constitute the largest portions of the aid, with significant funding also allocated to volunteer initiatives.
The King Salman Humanitarian Aid and Relief Center (KSrelief) has significantly expanded its global reach, announcing a total of $8.54 billion in humanitarian assistance. This aid has been distributed through 4,404 projects across 114 countries as of June 2026, underscoring the center's extensive operations.
Yemen remains the primary recipient of KSrelief's aid, having received $4.79 billion, which represents 56% of the total assistance. This substantial support targets critical sectors including food security, health, education, shelter, and water and sanitation. Syria and Palestine follow as major beneficiaries, with aid totaling $583.38 million and $542.48 million, respectively.
Other nations receiving significant support include Somalia ($257.17 million), Pakistan ($228.34 million), and Sudan ($190.63 million). The aid to these countries also focuses on essential needs such as food security, healthcare, education, and shelter.
Across all sectors, food security and agriculture projects have received the largest share of funding, amounting to $2.31 billion through 1,191 initiatives. Health projects follow closely with $2.13 billion allocated to 741 projects. The center has also implemented a considerable number of volunteer projects, totaling $155.81 million, with a strong emphasis on healthcare initiatives.
Originally published by Saudi Gazette in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.